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Abstract
Background: It is ethically controversial whether medical doctors are morally permitted to ration the
care of their patients at the bedside. To explore whether general practitioners in fact do ration in this
manner we conducted a study within primary care in the Danish public healthcare system. The purpose of
the study was to measure the extent to which general practitioners (GPs) would be willing to factor in
cost-quality trade-offs when prescribing medicine, and to discover whether, and if so to what extent, they
believe that patients should be informed about this.
Methods:  Postal survey of 600 randomly selected Danish GPs, of which 330 responded to the
questionnaire. The Statistical Package for the Social Sciences (SPSS, version 14.0) was used to produce
general descriptive statistics. Significance was calculated with the McNemar and the chi-square test. The
main outcome measures of the study were twofold: an assessment of the proportion of GPs who, in a
mainly hypothetical setting, would consider cost-quality trade-offs relevant to their clinical decision-making
given their economic impact on the healthcare system; and a measure of the extent to which they would
disclose this information to patients.
Results: In the hypothetical setting 95% of GPs considered cost-quality trade-offs relevant to their clinical
decision-making given the economic impact of such trade-offs on the healthcare system. In all 90% stated
that this consideration had been relevant in clinical decision-making within the last month. In the
hypothetical setting 55% would inform their patients that they considered a cost-quality trade-off relevant
to their clinical decisions given the economic impact of such trade-offs on the healthcare system. The most
common reason (68%) given for not wanting to inform patients about this matter was the belief that the
information would not prove useful to patients. In the hypothetical setting cost-quality trade-offs were
considered relevant significantly more often in connection with concerns about costs to the patient (86%)
than they were in connection with concerns about costs to the healthcare system (55%; p < 0.001).
Conclusion:  Although readiness to consider cost-quality trade-offs relevant to clinical decisions is
prevalent among GPs in Denmark, only half of GPs would disclose to patients that they consider this
relevant to their clinical decision-making. The results of this study raise two important ethical problems.
First, under Danish law physicians are required to inform patients about all equal treatments. The fact that
only a few GPs would inform their patients about all of the relevant treatments therefore seems to
contravene Danish law. Second, it is ethically controversial that physicians act as economic gatekeepers.
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Background
How to allocate healthcare fairly when not all medical
needs can be met constitutes a major international health-
political challenge. In Denmark the topic of priority-set-
ting within healthcare entered the public agenda during
the mid-1990s when the Danish Council of Ethics pub-
lished a report[1] calling for a public debate on how to
prioritize healthcare; but since then the subject has hardly
been given any systematic public attention. The Danish
Institute for Rational Pharmacotherapy, however, has
made repeated efforts to create awareness about the costs
of pharmaceuticals, especially among general practition-
ers (GPs). Recently, the Danish Board of Technology has
also tried to reintroduce priority-setting to the public
agenda[2]. The impact of this report on the public debate
and on the allocation of healthcare remains to be seen.
For the moment, however, there is no ongoing Danish
debate on priority-setting.
The focus of this article is on priority-setting undertaken
by Danish GPs at the clinical level. Priority-setting at the
clinical level is often called bedside rationing. In an influen-
tial article Peter Ubel and Susan Goold have defined bed-
side rationing in the following manner:
Bedside rationing is the withholding by a physician of
a medically beneficial service because of that service's
cost to someone other than the patient. Three condi-
tions must be met, in our view, before a physician's
action qualifies as bedside rationing. The physician
must 1) withhold, withdraw, or fail to recommend a
service that, in the physician's best clinical judgment,
is in the patient's best medical interests; 2) act prima-
rily to promote the financial interests of someone
other than the patient [including an organization,
society at large, or the physician himself or herself];
and 3) have control over the use of the medically ben-
eficial service[3].
GPs in Denmark today do not appear to be being strongly
encouraged to undertake bedside rationing by healthcare
regulations or official professional ethics codes, though
certain drivers in this direction can certainly be detected.
To begin with, in their original report on priority-setting
the Danish Council of Ethics touched upon the issue of
setting priorities at the clinical level and favoured granting
physicians a certain amount of clinical autonomy in this
respect [2]. Second, in their professional oath (Lægeløftet)
physicians promise to apply their skills to the benefit of
both society and their fellow human beings[4]. Third, and
perhaps most importantly, GPs are required by their con-
tract with the state to assist their region in ensuring eco-
nomically responsible use of reimbursable prescriptive
pharmaceuticals [5].
Although no regulation clearly requires Danish GPs to
perform bedside rationing, weak encouragement can be
detected. Bedside rationing is, however, controversial. It
raises important questions about the way in which physi-
cians should balance their professional duties to their
patients and the healthcare system [6]. Two central con-
siderations are in play: should physicians ration at the
bedside, and if so, should they disclose this fact to their
patients?
About the first consideration, it has been argued that
rationing is necessary, and that since physicians are best
able to recognize appropriate cases for rationing they
should sometimes ration at the bedside. Efforts have been
made, moreover, to find ways of involving physicians in
rationing while shielding the fairness and trust that are
central to the patient-physician relationship [7,8]. It has
been claimed, of course, that bedside rationing should be
avoided because it undermines the physician-patient rela-
tionship [9-11].
The second consideration concerns whether physicians
should be implicit or explicit about rationing, i.e. whether
patients should be routinely informed about rationing
when it occurs. Some claim that openly acknowledged
rationing should be avoided since it creates dissatisfaction
among physicians and patients [12] and prompts social
conflict over resource allocation [13]. Others argue that
unacknowledged rationing is undesirable because it is
inconsistent with the ideals of communication [8],
informed consent and democratic participation [14-16].
Although there are studies of physicians' [17-21], patients'
[22], and citizens' [23-25] attitudes to rationing, data on
GP attitudes to bedside rationing within primary care are
limited. To date there have been no studies of the ques-
tion whether GPs are willing to inform their patients
about bedside rationing, and no investigation of the rea-
sons GPs would give for not informing patients (where
they would not).
The aim of this article is twofold. First, we try to establish
the proportion of GPs today who consider it acceptable to
trade-off a treatment's health effect or side-effects against
its cost given the treatment's economic impact on the
healthcare system. Second, we measure the extent to
which those GPs who do consider such trade-offs accept-
able would inform their patients about this.
To investigate GP attitudes we presented participants with
an ethical dilemma, mainly of hypothetical design. This
dilemma was designed so as to allow us to investigate
whether GPs solely attend to the interests of their patients
when they prescribe medicine, or whether they also act asBMC Health Services Research 2008, 8:192 http://www.biomedcentral.com/1472-6963/8/192
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economic gatekeepers who steward the resources of the
healthcare system.
In the remainder of this article trade-offs between effect or
side-effects and cost are referred to as cost-quality trade-offs.
Methods
Study design and participants
The study proceeded in two parts: in the main study a
questionnaire was mailed to a random sample of 600 GPs
drawn from the Danish Medical Association's department
of registration. The questionnaire, which was in Danish,
was accompanied by a letter explaining the purpose of the
study and that it was voluntary to participate. It also guar-
anteed confidentiality. Non-responders received up to
three reminders. Subsequently, a one-page questionnaire
was sent to all non-respondents to the first questionnaire.
The first part took place in January 2007; the second in
February 2007.
Main questionnaire
The main questionnaire was constructed on the basis of
theoretical considerations. It evolved following a series of
four semi-structured in-depth interviews with GPs partly
recruited through personal contacts and partly selected
randomly from a list of all GPs in Copenhagen. The inter-
views, which were conducted by SL, were taped, and the
tapes were carefully monitored so that common themes
reported by the respondents could be located. Most of the
participants in the interviews mentioned treatment of
hypertension and high cholesterol as examples where they
might consider trading cost off with quality of care.
Against this background two hypothetical cases were con-
structed.
The first concerned hypertension. It was described as fol-
lows. "A 41-year-old woman goes to her GP. Examina-
tions have repeatedly shown that her blood pressure is too
high and non-pharmacological initiatives have proven
ineffective. A number of medical treatments exist. There is
general agreement that these are identical in effect but dif-
fer in their side-effects".
The second case concerned high serum cholesterol. "A 65-
year-old man suffering from high serum cholesterol visits
his physician for a check-up. An examination shows that,
despite treatment with 40 mg. simvastatin, he continues
to have an LDL above 5. A new treatment is planned".
After being presented with these cases, the participants
were given information about the typical pharmaceuticals
for hypertension and high serum cholesterol (low density
lipoprotein [LDL] > 5 mmol/liter in spite of daily treat-
ment with 40 mg simvastatin). They were also told about
the costs of the various treatments, both to the patient and
to the healthcare system.
All participants were asked to indicate on a four-point
ordinal scale how relevant a trade-off between the treat-
ment's health effect and side-effects and its cost would be
in their clinical decision-making – given concern about
the patient's costs (the patient's co-payment) and given
concern about costs to the healthcare system (Figure 1).
They were also asked which of the specified alternative
treatments they would spontaneously inform their
patients about. Participants who indicated that they
would not disclose all treatments were asked to indicate,
again on a four-point ordinal scale, the importance of the
following three claims in this decision: (i) The informa-
tion is of no use to patients; (ii) I have no wish to enter
into a discussion with my patients; and (iii) I have no time
to give the information. Participants were also given the
opportunity to list other reasons for not providing infor-
mation.
Participants who considered a cost-quality trade-off rele-
vant to clinical decision-making in the hypothetical cases
were asked whether they would inform their patient about
this. Those who would not inform their patients were
asked, once more, to indicate the relevancy of the three
claims listed above for this decision on a four-point ordi-
nal scale. Those participants who claimed that a cost-qual-
ity trade-off would not be of any relevance to their clinical
decision-making were asked which of the following three
reasons was important in this decision: (i) I focus exclu-
sively on the health gains of the patient; (ii) I believe that
all of the specified treatments in the scheme are equally
beneficial; and (iii) I based my decisions on other consid-
erations.
Besides these questions, we asked all participants how
often, on a four-point ratio scale, cost-quality trade-offs
had, in general, been relevant to their clinical decision-
making over the last month.
Finally, all participants were asked to specify their age, sex
and number of years as GP, together with the locality of
their practice.
Before the study proper was conducted, the questionnaire
and the covering letter were tested in five pilot interviews
with GPs conducted by SL. Some of the respondents from
the first series of pilot interviews were included in a new
series of interviews. The rest were randomly selected. This
led to some changes in formulations and graphics. Further
testing in a pilot survey of twenty randomly selected GPs
did not prompt any additional changes.BMC Health Services Research 2008, 8:192 http://www.biomedcentral.com/1472-6963/8/192
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Questionnaire for non-respondents
A follow-up one-page questionnaire was sent to non-
respondents to the main questionnaire (N = 267). This
asked questions about how relevant, given the overall
needs of the healthcare system, they consider cost-quality
trade-offs to be in clinical decision-making, and questions
about the provision of information about this to patients.
Ethics
The participants were guaranteed anonymity. In Danish
law, no approval of the study by a research ethics commit-
tee was required.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS, ver-
sion 14.0) was used to produce general descriptive statis-
tics. Significance was calculated with the McNemar test
and the chi-square test.
Results
Respondents
Of the 600 questionnaires dispatched in the main study,
330 were completed and returned (55% response rate).
Three questionnaires were undeliverable. Of the respond-
ents, 211 (64%) were men and 117 (36%) women (two
respondents did not specify their sex). The mean age was
53 years (four people did not specify their age). 46% of
the sample worked in the eastern part of Denmark and
52% worked in the western part. 2% did not specify which
part of the country they worked in.
The distribution of age, sex, and locality (i.e. eastern ver-
sus western part of Denmark) did not differ from the dis-
tribution in the general population of GPs in Denmark
(data not shown).
Bedside rationing
The majority of participants considered trade-offs
between a treatment's quality and its costs relevant to clin-
ical decision-making (Table 1). Trade-offs were consid-
The two central questions Figure 1
The two central questions.
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Table 1: Percentage of GPs who consider trade-offs between costs and health effects* based on concerns about costs to the patient 
and costs to the healthcare system to be relevant to clinical decision-making (N = 327)
Concern for, % Very relevant Somewhat relevant Slightly relevant Not relevant
Patient 52 34 9 4
Healthcare system 34 41 19 6
*There was no significant difference between how relevant participants thought it to be to trade-off costs and side-effects (hypertension) and costs 
and effects (cholesterol) out of concern of the healthcare system nor out of concern for the patient.
Missing data: 3 participantsBMC Health Services Research 2008, 8:192 http://www.biomedcentral.com/1472-6963/8/192
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ered relevant significantly more often when they were
connected with concerns about costs incurred by the
patient than they were in connection with concerns about
costs to the healthcare system (McNemar test, p < 0.001).
90% of participants (296 of 330) reported that, out of eco-
nomic concern about the healthcare system, a cost-quality
trade-off had been relevant to their clinical decision-mak-
ing within the last month.
Information
As can be seen in Table 2, significantly fewer respondents
would inform patients about their attitude to cost-quality
trade-offs when that attitude was based on concern about
costs to the healthcare system than would do so when
costs to the patient were at issue (McNemar test, p <
0.001). 
Participants were generally less prone to disclose informa-
tion about expensive treatments than they were to dis-
close similar information about cheaper ones (Figure 2).
Reasons for non-disclosure
The belief that the 'information would not be useful to
patients' was most frequently reported as the principal
reason for not informing patients about treatments; it was
also most frequently reported as the principal reason for
not informing patients about cost-quality trade-offs
(Table 3).
The second most reported reason for not providing infor-
mation, described as 'various other reasons', included rea-
sons the physicians themselves listed. Most of these
reasons were in fact more or less blank statements that dis-
closure would not be useful, or brief explanations of why
the physician believed that information would not be use-
ful to patients. Thus the statements incorporated phrases
such as "I do not believe the patient can use the informa-
tion" and "I wish to avoid confusing the patient".
Reasons for not making trade-offs
A small number of participants (19) said that they would
not consider a cost-quality trade-off based on economic
concern about the healthcare system relevant to clinical
decision-making. These respondents all stated that they
focused exclusively on the health outcomes for the
patient, and of them 21% (4 of 19) explained that they
would not make trade-offs because the specified treat-
ments were all equally beneficial, while 26% (5 of 19)
said they had other reasons for not making trade-offs.
Determinants of reported rationing
We failed to demonstrate any association between physi-
cians' age, sex, locality, and years in practice and the
degree of reported rationing.
Results of the non-respondent survey
In the non-respondent survey, 87% (96 of 110) of the par-
ticipants believed that a cost-quality trade-off, based on
economic concern about the healthcare system, would in
some cases be relevant to clinical decision-making. This
result did not differ significantly from the result of the
main study (chi-square test). 20% (19 of 94) would not
tell their patients that the relevant trade-off had influ-
enced their clinical decision-making. Significantly more
participants in the non-respondent survey than in the
main study would inform patients of their belief that a
cost-quality trade-off was relevant (chi-square test p <
0.001).
Discussion
The present study reinforces the idea that GPs and those
working in health policy need to address two important
ethical questions. First, the widespread willingness of GPs
to perform bedside rationing is ethically controversial.
Such rationing has been criticized by both physicians and
bioethicists [9,9-11], though, of course, some observers
consider it ethically unobjectionable[8,26]. So: how ethi-
cal is bedside rationing? What are its morally questionable
features?
Second, the finding that physicians are minded to inform
their patients about their engagement with cost-quality
trade-offs to only a limited degree may be equally contro-
versial. Although implicit or undisclosed rationing has its
defenders [12,27], recent studies show that patients and
Table 2: Percentage of GPs who inform patients of their belief that, in view of concerns about costs to the patient and costs to the 
healthcare system, they consider trade-offs between costs and health benefits to be relevant to clinical decision-making
Concern for, % Treatment Information about trade-off *P value
Patient (N = 312) Effect 85 P < 0.045
Patient (N = 310) Side-effect 80
System (N = 305) Effect 55 P < 0.028
System (N = 296) Side-effect 50
*McNemar test used to assess whether physicians have the same pattern of information when they make trade offs in cases of side-effect and cases 
of effect
Missing data: up to 12 participantsBMC Health Services Research 2008, 8:192 http://www.biomedcentral.com/1472-6963/8/192
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citizens prefer to be informed about whether or not
aspects of clinical provision are subject to rationing by
physicians [22,23]. More generally, undisclosed rationing
has been characterized as morally inappropriate
[15,16,28]. To this last point one may respond that, in
point of fact, our study does not measure physicians' atti-
tudes towards undisclosed rationing. The participants
reporting that they would not inform their patients that
they consider a cost-quality trade-off relevant to clinical
decisions may choose not to do this because ultimately
they would not ration. It is perfectly possible that they
would consider cost-quality trade-offs relevant to clinical
decision-making, but that this consideration would be
trumped by other factors they deem clinically relevant. If,
at the end of the day, they do not ration, why should they
inform their patients that they consider a cost-quality
trade-off relevant but not decisive in making their clinical
decisions? To this we have two responses:
First, as stated above, only 35% of participants in the case
of hypertension, and only up to 53% in the case of choles-
terol, would even inform patients about the expensive
treatments. This seems to indicate that GPs do not merely
consider cost-quality trade-offs relevant to clinical deci-
sion-making but actually engage in such trade-offs with-
out informing patients that this is what they are doing.
Second, if one accepts that physician and patient will ide-
ally make clinical decisions together (shared decision-
making), then it remains problematic that GPs retain
information relevant to decision-making. How can
patients ever be truly involved in the decision-making
process if they are deprived information relevant to the
decisions of the physician?
The results of this study, we believe, raise two important
ethical problems. First, under Danish law physicians are
required to inform patients about all equal treat-
Percentages of the extent to which physicians inform patients about various antihypertensive and cholesterol lowering treat- ments (N = 330) Figure 2
Percentages of the extent to which physicians inform patients about various antihypertensive and cholesterol 
lowering treatments (N = 330). The treatments marked with †, ‡, and § indicate the most expensive therapies.
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Table 3: Reasons GPs judged to be the most important for not informing patients about treatments and making trade-offs between 
cost and health benefit
Side-effects Effects
Most important reason for not informing No info treatment
(N = 223)
No info trade-off
(N = 132)
No info treatment
(N = 160)
No info trade-off
(N = 128)
Information not useful to patients 63 59 55 68
Various other reasons 25 19 29 15
Unwillingness to enter discussion with patients 7 11 11 8
Lack of time 5 12 6 9
Missing data: up to 51 participantsBMC Health Services Research 2008, 8:192 http://www.biomedcentral.com/1472-6963/8/192
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ments[29]. The fact that only a few GPs would disclose all
relevant treatments seems to contravene this legal obliga-
tion. Second, it is ethically controversial that physicians
act as economic gatekeepers.
Our finding call, therefore, we believe, for a broad discus-
sion of undisclosed bedside rationing in healthcare
involving both health professionals and the public.
Strength and weaknesses
We now turn to indicate strengths and weaknesses of the
study. We believe it to be an advantage of our approach
that it is case-oriented: the obligation to consider a spe-
cific case may make physicians recognize attitudes they
were not aware of beforehand. We also believe it is a
strength of the study that it is based on a self-administered
questionnaire rather than on interviews. Studies show
that self-administered enquiries yield higher levels of
reporting on sensitive matters enquiries where the ques-
tions are put by interviewers [30]. Again, the sample of the
main study was relatively large; and the response rate,
though modest, was still slightly above the average
response rate for physicians [31].
Our study, however, also suffers from a number of limita-
tions. Mainly, it may seem to be a limitation that our
enquiries focused heavily on hypothetical cases. Hypo-
thetical questions constitute a sub-category of attitudinal
questions. In our questionnaire participants are con-
fronted with a type of situation to which they may not
have a clear-cut attitude. Research shows that when
respondents do not have a clear sense about an issue they
draw on different sources or aids. They may fall back on a
general impression about the category to which the spe-
cific issue relates, or they may draw on more general val-
ues [32]. This, however, does not necessarily present a
problem in our study. We have been interested in measur-
ing GPs' general willingness to engage in bedside ration-
ing and not specifically their attitudes to the presented
cases. Hence, if participants have reported general  atti-
tudes to bedside rationing, rather than narrower attitudes
to the specific cases they have been presented with, this is
only an advantage.
It would constitute a problem if participants answered in
what they believed was the 'politically correct' way, rather
than reporting whether they actually consider cost-quality
trade-offs relevant to clinical decisions. However, it is
quite unclear what the politically correct answers to the
questions in the questionnaire would be. GPs seem
required to attend to both the interests of their individual
patients and the economic effectiveness of the healthcare
system. This may have ensured that our participants
answered more truthfully than they would have done if
there had been a clear politically correct answer.
Clearly, the missing data in table 3 are far from negligible.
It could be that we failed to collect these data because par-
ticipants became tired of answering the same set of ques-
tions about why they do not inform patients of treatments
or trade-offs.
Other studies
A number of empirical studies have investigated the GP's
role in priority-setting. The study that is most similar to
ours is a recent investigation of bedside rationing among
general internists carried out in five European countries
[21]. In this investigation 82% of participants "agreed to
some extent with rationing". 56% reported that they had
rationed interventions within the last six months, and
37% reported that they "sometimes did not let their
patients know about the expensive alternative".
In our study 95% of the participants reported that they
considered cost-quality trade-offs serving the needs of the
healthcare system relevant to their clinical decision-mak-
ing. 90% reported that, with the needs of the healthcare
system in mind, they had actually treated a cost-quality
trade-off as relevant to their clinical decision-making
within the last month. Finally, up to 55% would inform
patients about their readiness to consider such cost-qual-
ity trade-offs in making clinical decisions.
In both studies, then, the majority of participants consid-
ered the rationing of care relevant; and, again in both
studies, a large proportion of the participants also
reported that often they often do not disclose rationing
information to patients.
Unfortunately, it is not possible to make a more precise
comparison, because the terminology, scales and design
used in the two studies differ too greatly. (A Danish ver-
sion of the survey instrument used to collect the data pro-
vided in this article is available in additional file 1.)
Further work
Finally, it would be interesting to examine the phenome-
non of bedside rationing in observational studies. This
would make it possible to obtain information about
whether GPs in fact ration at the bedside in a more direct
manner (though the response-effect created by the pres-
ence of an observer may, of course, introduce a potential
bias in such a study).
The divergence between the main and the non-respond-
ent study in respect of disclosure of information to
patients indicates a need for further research. The belief,
widespread among physicians, that information about
their readiness to factor in cost-quality trade-offs when
making clinical decisions is not useful to patients suggests
a need for further investigation also – it would of interest,BMC Health Services Research 2008, 8:192 http://www.biomedcentral.com/1472-6963/8/192
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clearly, to know whether such information is in fact
regarded as useful by the patients.
Conclusion
The results of this study showed that most GPs would con-
sider a trade-off between a treatment's cost and its quality
relevant to their clinical decision-making, in view both of
the costs to the healthcare system and the costs to the
patient. Approximately half of the participants would dis-
close to patients their belief that cost-quality trade-offs are
relevant to clinical decision-making given the cost of treat-
ment to the healthcare system. More physicians would
inform their patients about trade-offs where the relevant
costs were to be borne by the patient than would do so
where the costs were to be met by the healthcare system.
The secondary, non-respondent survey supported the
finding, made in the main study, that most participants
consider trade-offs relevant to clinical decision-making
when those trade-offs are connected with concerns about
costs carried by the healthcare system.
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